Human Drugs View

Product Information
Registration Number DR-XY33139
Generic Name Zoledronic Acid
Brand Name Aclasta
Dosage Strength 5 mg/100 mL
Dosage Form Solution for Intravenous Infusion
Classification Prescription Drug (RX)
Pharmacologic Category Biphosphonate
Packaging Colorless plastic vial with rubber and aluminum cap with flip-off component
Manufacturer Novartis Pharma Stein AG
Country of Origin Switzerland
Trader
Importer Novartis Healthcare Phils., Inc.
Distributor
Application Type Renewal
Issuance Date 23 February 2022
Expiry Date 27 March 2027